These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31044247)

  • 1. Quantification of Herbal Mixtures Containing Cumyl-PEGACLONE-Is Inhomogeneity Still an Issue?
    Halter S; Mogler L; Auwärter V
    J Anal Toxicol; 2020 Jan; 44(1):81-85. PubMed ID: 31044247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: Update of the German situation in summer 2018.
    Ernst L; Langer N; Bockelmann A; Salkhordeh E; Beuerle T
    Forensic Sci Int; 2019 Jan; 294():96-102. PubMed ID: 30497049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Synthetic Cannabinoid CUMYL-PEGACLONE in E-Cigarette Oil and Hair.
    Jiao TF; Li YQ; Kang G; Chen SS; Cheng LH
    Fa Yi Xue Za Zhi; 2022 Oct; 38(5):595-600. PubMed ID: 36727175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: Update of the German situation in early 2017.
    Ernst L; Brandhorst K; Papke U; Altrogge A; Zodel S; Langer N; Beuerle T
    Forensic Sci Int; 2017 Aug; 277():51-58. PubMed ID: 28601726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a thermal degradation product of CUMYL-PEGACLONE and its detection in biological samples.
    Nash C; Glowacki L; Gerostamoulos D; Pigou P; Scott T; Kostakis C
    Drug Test Anal; 2019 Oct; 11(10):1480-1485. PubMed ID: 31479592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity profiling of Cumyl-PEGACLONE variants at the CB
    Janssens L; Cannaert A; Connolly MJ; Liu H; Stove CP
    Drug Test Anal; 2020 Sep; 12(9):1336-1343. PubMed ID: 32490586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia.
    Tiemensma M; Rutherford JD; Scott T; Karch S
    Forensic Sci Med Pathol; 2021 Mar; 17(1):3-9. PubMed ID: 33185835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac effects of 5F-Cumyl-PEGACLONE.
    Esdar N; Pawlik E; Eickhoff SB; Raupach A; Ritz-Timme S; Mayer F
    Int J Legal Med; 2024 May; 138(3):823-831. PubMed ID: 38214738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling of synthesis-related impurities of the synthetic cannabinoid Cumyl-5F-PINACA in seized samples of e-liquids via multivariate analysis of UHPLC-MS
    Münster-Müller S; Matzenbach I; Knepper T; Zimmermann R; Pütz M
    Drug Test Anal; 2020 Jan; 12(1):119-126. PubMed ID: 31307120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large-scale evaluation of ion mobility spectrometry for the rapid detection of synthetic cannabinoid receptor agonists in infused papers in prisons.
    Norman C; McKirdy B; Walker G; Dugard P; NicDaéid N; McKenzie C
    Drug Test Anal; 2021 Mar; 13(3):644-663. PubMed ID: 33058556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and quantitation of synthetic cannabinoid receptor agonists in infused papers from prisons in a constantly evolving illicit market.
    Norman C; Walker G; McKirdy B; McDonald C; Fletcher D; Antonides LH; Sutcliffe OB; Nic Daéid N; McKenzie C
    Drug Test Anal; 2020 Apr; 12(4):538-554. PubMed ID: 31944624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation in commercial smoking mixtures containing third-generation synthetic cannabinoids.
    Frinculescu A; Lyall CL; Ramsey J; Miserez B
    Drug Test Anal; 2017 Feb; 9(2):327-333. PubMed ID: 27161591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples.
    Mogler L; Wilde M; Huppertz LM; Weinfurtner G; Franz F; Auwärter V
    Drug Test Anal; 2018 May; 10(5):886-891. PubMed ID: 29314750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the Synthetic Cannabinoid 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide (CUMYL-4CN-BINACA) in Plant Material and Quantification in Post-Mortem Blood Samples.
    Yeter O
    J Anal Toxicol; 2017 Nov; 41(9):720-728. PubMed ID: 28977413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumyl-CBMICA: A new synthetic cannabinoid receptor agonist containing a cyclobutyl methyl side chain.
    Halter S; Pulver B; Wilde M; Haschimi B; Westphal F; Riedel J; Pütz M; Schönberger T; Stoll S; Schäper J; Auwärter V
    Drug Test Anal; 2021 Jan; 13(1):208-216. PubMed ID: 33037749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Novel Psychoactive Substance Cumyl-CH-MEGACLONE: Human Phase-I Metabolism, Basic Pharmacological Characterization and Comparison to Other Synthetic Cannabinoid Receptor Agonists with a γ-Carboline-1-One Core.
    Haschimi B; Giorgetti A; Mogler L; Nagy TZ; Kramer S; Halter S; Boros S; Dobos A; Hidvégi E; Auwärter V
    J Anal Toxicol; 2021 Mar; 45(3):277-290. PubMed ID: 32514544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.
    Angerer V; Mogler L; Steitz JP; Bisel P; Hess C; Schoeder CT; Müller CE; Huppertz LM; Westphal F; Schäper J; Auwärter V
    Drug Test Anal; 2018 Mar; 10(3):597-603. PubMed ID: 28670781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and quantification of synthetic cannabinoids in 'spice-like' herbal mixtures: a snapshot of the German situation in the autumn of 2012.
    Langer N; Lindigkeit R; Schiebel HM; Ernst L; Beuerle T
    Drug Test Anal; 2014; 6(1-2):59-71. PubMed ID: 23723183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Synthetic Cannabinoids: Development and Validation of a Novel Liquid Chromatography Quadrupole Time-of-Flight Mass Spectrometry Assay for Real-Time Detection.
    Krotulski AJ; Mohr ALA; Logan BK
    J Anal Toxicol; 2020 Apr; 44(3):207-217. PubMed ID: 31909808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smart drugs: green shuttle or real drug?
    Cornara L; Borghesi B; Canali C; Andrenacci M; Basso M; Federici S; Labra M
    Int J Legal Med; 2013 Nov; 127(6):1109-23. PubMed ID: 23842669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.